Our Mission
Because we know that one of your main preoccupations is to optimize your preclinical and discovery studies, INOVOTION has established a unique and cutting-edge in vivo technology.

As a Contract Research Organisation (CRO) that is dedicated to in vivo evaluation for drug discovery, particularly in oncology, INOVOTION is a sought-after partner for drug discovery pharmaceutical and biotech companies as well as academic labs all over the world.

Our main missions are to:

Help you to find the best anticancer candidate treatment
Detect the first in vivo toxicity effects of your candidate compounds
Improve the productivity of your preclinical and discovery process by maximizing your lead optimization phase
Accelerate the overall drug discovery process to answer unmet medical needs in oncology

Our Vision
Due to our flexibility, can-do spirit and human size, we can plan, set up and run a tailored experimental protocol for your specific projects.

For each of our clients, INOVOTION provides a personalized solution.

Our scientific team brings a wealth of knowledge in oncology, target validation and toxicity and a close collaboration with our clients to always get a successful outcome.

Your success is our success.

Overall lead optimization and preclinical phases are the most expensive phases of drug development, representing 1/4 of the total cost. At the same time, these steps have a poor predictivity: less than 5%. That’s why INOVOTION pays particular attention to standardize its studies (biological reagent and reference material used), to make relevant study design, data analysis and report all within a framework reproducible with standard operating procedure.

Inovotion Sas products

Inovotion SAS - In Vivo Technology